SCHEMBL1616586

SCHEMBL1616586

O=CC1CC=CCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11782871 0.75
SCHEMBL4138420 0.72
SCHEMBL11089960 0.70
SCHEMBL6245019 0.67
SCHEMBL290683 0.65
SCHEMBL16806266 0.62
SCHEMBL445334 0.62
SCHEMBL10400524 0.62
SCHEMBL8884713 0.62
SCHEMBL6245016 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1341927-B1 METHOD OF PREPARING 3-¬2-{(METHYLSULFONYL)OXY}ETHOXY|-4-(TRIPHENYLMETHOXY)-1-BUTANOL, METHANE SULFONATE PPG IND OHIO INC (US) 2006-08-02 EP claimed
US-6300106-B1 FORMING S-ISOMER OR R-ISOMER OF (3,6-DIHYDRO-2H-PYRAN-2-YL)-METHANOL VIA A PROCESS WHICH PRODUCES A RACEMIC MIXTURE OF INTERMEDIATE REACTION PRODUCTS, RESOLVING TO SELECTIVELY PRODUCE S ISOMER PPG INDUSTRIES OHIO, INC. 2001-10-09 US claimed
EP-0447758-B1 Process for the preparation of unsaturated and saturated carbonyl compounds BASF AG (DE) 1994-08-03 EP claimed
EP-0473021-B1 2-(3'-butenyl)-3,4-dihydro-2H-pyranes, their production and their use GOLDSCHMIDT AG TH (DE) 1994-05-04 EP claimed
US-5189184-A Reacting 2-formyldihydropyran with allyl magnesium halide or allyl lithium in presence of ether or ether/alkane mixture as solvent; hydrolysis; etherfication with alkyl halide TH. GOLDSCHMIDT AG (DE) 1993-02-23 US claimed
EP-0473021-A1 2-(3'-butenyl)-3,4-dihydro-2H-pyranes, their production and their use Th. Goldschmidt AG (DE) 1992-03-04 EP claimed
US-8242290-B2 Process for the preparation of renin inhibitors VITAE PHARMACEUTICALS, INC. (US) 2012-08-14 US disclosed
US-7923479-B2 Superabsorbent foam, method for the production thereof, and use thereof BASF AKTIENGESELLSCHAFT (DE) 2011-04-12 US disclosed
US-7838567-B2 Using mixture containing crosslinker and surfactant; dissolving a pressurized gas BASF AKTIENGESELLSCHAFT (DE) 2010-11-23 US disclosed
US-20100256400-A1 PROCESS FOR THE PREPARATION OF RENIN INHIBITORS VITAE PHARMACEUTICALS, INC. 2010-10-07 US disclosed
EP-1448242-B1 CROSSLINKED POLYAMINE COATING ON SUPERABSORBENT HYDROGELS BASF SE (DE) 2010-06-16 EP disclosed
EP-1858998-B1 SUPERABSORBING FOAM, METHOD FOR THE PRODUCTION AND USE THEREOF BASF SE (DE) 2010-06-09 EP disclosed
WO-2009038719-A1 PROCESS FOR THE PREPARATION OF RENIN INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2009-03-26 WO disclosed
US-4939280-A Aluminum phosphate catalysts with zeolitic structure molcular sieves BASF AKTIENGESELLSCHAFT (DE) 1990-07-03 US disclosed
EP-0222117-B1 METHOD FOR THE PRODUCTION OF UNSATURATED CYCLIC ALCOHOLS Degussa Aktiengesellschaft (DE) 1990-01-10 EP disclosed
EP-0291807-A1 Transformation of 1,3-dioxanes into 4-oxa-aldehydes BASF Aktiengesellschaft (DE) 1988-11-23 EP disclosed
EP-0291806-A1 Transformation of 1,3-dioxanes into 4-oxa-aldehydes BASF Aktiengesellschaft (DE) 1988-11-23 EP disclosed
EP-0222117-A2 Method for the production of unsaturated cyclic alcohols Degussa Aktiengesellschaft (DE) 1987-05-20 EP disclosed
EP-0126712-B1 CURABLE COMPOSITION AND USE THEREOF CIBA-GEIGY AG (CH) 1986-12-10 EP disclosed
EP-0199210-A2 Conversion of 1,3-dioxanes into 4-oxa-aldehydes BASF Aktiengesellschaft (DE) 1986-10-29 EP disclosed